## Review setup

- **Input scope** Title, author list, arXiv metadata, and abstract page only. No full manuscript text, figures, tables, or supplementary materials were provided.
- **Assessment boundary** This review is limited to the claims and evidence visible in the supplied abstract page. No methodological details, experimental results, or validation data are available for assessment.
- **Shared manuscript claim summary** The work introduces PROTEAN, an LLM-agent-based system for text-guided protein structure editing, positioned as an advance beyond de novo generation. The title poses a question about whether LLM agents can perform this task, implying an affirmative demonstration.
- **Visible evidence base** Title, abstract page metadata, and submission history. No technical content, results, or figures are accessible.
- **Missing materials affecting confidence** Full text, all figures, tables, methods descriptions, experimental protocols, benchmark definitions, baseline comparisons, and any quantitative results. The absence of these materials makes substantive evaluation impossible.

## Reviewer

- **Overall assessment** The manuscript addresses a potentially interesting question in computational protein design, namely whether LLM agents can perform targeted editing of existing protein structures rather than generating new ones from scratch. However, the provided material is limited to a title and abstract page with no technical content. The scientific case cannot be evaluated from the supplied evidence. The framing is provocative but the substance is entirely inaccessible.
- **Who would be interested in the results, and why** Researchers in computational protein design, protein engineering, and AI-driven structural biology would likely be interested if the claims hold. The question of text-guided editing of existing structures has practical relevance for protein engineering applications where targeted modifications are needed rather than full de novo design. The LLM-agent angle may also attract the AI-for-science community.
- **Major strengths** From the limited material available, the only identifiable strength is the novelty of the research question. The distinction between de novo generation and structure editing is conceptually meaningful and could represent a useful contribution to the field if properly executed.
- **Major Concerns** 
  - **Concern ID** R1-M1
  - **Severity** Major
  - **Blocking** Yes
  - **Axis** Evidence sufficiency
  - **Claim pointer** The manuscript claims that LLM agents can perform text-guided protein structure editing, as implied by the title and the framing of the work.
  - **Evidence pointer** Location not provided. No methods, results, or validation data are available in the supplied material.
  - **Concern** The entire technical content of the manuscript is absent from the provided material. There is no description of the PROTEAN architecture, no experimental setup, no benchmark definitions, no baseline comparisons, and no quantitative results. The core claim cannot be assessed in any form.
  - **Why it matters** The central scientific claim of the manuscript is that LLM agents can successfully perform text-guided protein structure editing. Without access to the methods and results, there is no way to determine whether this claim is supported, what the performance levels are, how the approach compares to existing methods, or whether the results are reproducible.
  - **Resolution test** Provide the full manuscript text including methods, results, figures, and tables. The claim can then be evaluated against the presented evidence.
  - **Concern ID** R1-M2
  - **Severity** Major
  - **Blocking** Yes
  - **Axis** Claim substantiation
  - **Claim pointer** The title implies that PROTEAN goes "beyond de novo generation" and that the work demonstrates a capability for text-guided protein structure editing.
  - **Evidence pointer** Location not provided. No comparative data against de novo generation methods or any editing benchmarks are visible.
  - **Concern** The positioning of the work as an advance beyond de novo generation requires comparative evidence. The supplied material contains no information about how PROTEAN performs relative to existing de novo generation methods, what specific editing tasks were tested, or what metrics were used to evaluate success.
  - **Why it matters** The claim of going "beyond" an existing paradigm requires demonstration of superiority or at least distinct capability. Without comparative data, the claim is unsupported and potentially misleading.
  - **Resolution test** Provide benchmark results comparing PROTEAN against relevant de novo generation baselines on editing tasks, with clear metrics and statistical significance testing.
- **Minor Comments** 
  - **Concern ID** R1-m1
  - **Severity** Minor
  - **Axis** Clarity
  - **Affected element** Title
  - **Evidence pointer** Title as provided
  - **Issue** The title is phrased as a question, which is unconventional for a research paper and creates ambiguity about whether the work demonstrates a positive result or merely explores feasibility.
  - **Required correction** Rephrase the title to make a definitive statement about what the work demonstrates, or clarify in the abstract whether the answer to the question is affirmative, negative, or mixed.
  - **Concern ID** R1-m2
  - **Severity** Minor
  - **Axis** Completeness
  - **Affected element** Abstract
  - **Evidence pointer** Abstract page as provided
  - **Issue** The abstract page contains no abstract text. The only substantive content is the title and metadata. This is likely a submission artifact, but it means the provided material contains no summary of the work.
  - **Required correction** Ensure the full abstract is included in any version of the manuscript provided for review.
- **Technical failings that need to be addressed before the case is established** R1-M1 and R1-M2 are both blocking. The absence of all technical content means the case is not established from the provided evidence. No technical failing can be identified beyond the complete lack of accessible material.
- **Assessment against Nature-style criteria** 
  - **Originality** The question of text-guided protein structure editing is potentially original, but this cannot be confirmed without seeing the full manuscript and understanding how it differs from existing approaches.
  - **Scientific importance** The topic is relevant to protein engineering and design, but the importance of the specific contribution cannot be assessed without results.
  - **Interdisciplinary readership** The topic bridges AI, computational biology, and protein engineering, which could attract a broad readership. However, the actual breadth of appeal depends on the quality and significance of the demonstrated results.
  - **Technical soundness** Cannot be assessed. No technical content is available.
  - **Readability for nonspecialists** Cannot be assessed. No text is available beyond the title.
- **Recommendation posture** Currently not established from the provided evidence. The manuscript cannot be evaluated in its present form. A full manuscript with methods, results, and validation data is required before any meaningful assessment can be made.

## Risk / unsupported claims

- The claim that LLM agents can perform text-guided protein structure editing is unsupported and unevaluable from the supplied material.
- The claim that the work goes "beyond de novo generation" is unsupported and unevaluable from the supplied material.
- Any implication that PROTEAN represents a functional or effective system is unsupported and unevaluable from the supplied material.